Lv1
36 积分 2022-11-10 加入
Value-based medicine and pharmacoeconomics
1个月前
已完结
Reporting Pharmacoeconomic Evaluations
1个月前
已完结
National value-based pricing negotiation for oncology drugs — lessons from China
1个月前
已完结
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing
1个月前
已完结
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing
2个月前
已完结
Cost-effectiveness analysis of an orphan drug tebentafusp in patients with metastatic uveal melanoma and a call for value-based pricing
2个月前
已完结
A Markov cost-utility analysis of escitalopram and duloxetine for the treatment of major depressive disorder
2个月前
已完结
Efficacy, safety and cost of emicizumab prophylaxis in haemophilia A patients with inhibitors: A nationwide observational study in Taiwan
2个月前
已完结
The long‐term clinical benefits and economic costs associated with increased use of prophylaxis among patients with haemophilia A in China: Population‐based predictions from 2018 to 2033
2个月前
已完结
All Cause Mortality and Causes of Death in People with Hemophilia: A Systematic Review and Meta Analysis
3个月前
已完结
皖公网安备34019202002308
